{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:35:48Z","timestamp":1648895748563},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00059-014-4157-3","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T06:30:48Z","timestamp":1413268248000},"page":"803-807","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Akutes Koronarsyndrom und antithrombozyt\u00e4re Therapie"],"prefix":"10.1007","volume":"39","author":[{"given":"T.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"4157_CR1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/eurheartj\/ehi238","volume":"26","author":"Lenzen","year":"2005","unstructured":"Lenzen MJ, Boersma E, Bertrand ME et al (2005) Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J 26:1169\u20131179","journal-title":"Eur Heart J"},{"key":"4157_CR2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"Task","year":"2012","unstructured":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569\u20132619","journal-title":"Eur Heart J"},{"key":"4157_CR3","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S et al; ESC Committee for Practice Guidelines (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999\u20133054","journal-title":"Eur Heart J"},{"key":"4157_CR4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/HJR.0b013e328338e5da","volume":"17","author":"Bauer","year":"2010","unstructured":"Bauer T, Gitt AK, Zahn R et al (2010) Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence. Eur J Cardiovasc Prev Rehabil 17:576\u2013581","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"4157_CR5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"4157_CR6","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.CIR.99.1.e1","volume":"99","author":"Gawaz","year":"1999","unstructured":"Gawaz M, Neumann FJ, Schomig A (1999) Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy. Circulation 99:E1\u2013E11","journal-title":"Circulation"},{"key":"4157_CR7","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Authors","year":"2014","unstructured":"Authors\/Task Force members, Windecker S, Kolh P et al (2014) 2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541\u20132619","journal-title":"Eur Heart J"},{"key":"4157_CR8","doi-asserted-by":"crossref","unstructured":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2:349\u2013360","DOI":"10.1016\/S0140-6736(88)92833-4"},{"key":"4157_CR9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jacc.2007.10.037","volume":"51","author":"Serebruany","year":"2008","unstructured":"Serebruany VL (2008) Switching thienopyridines: hypothetical versus real risks. J Am Coll Cardiol 51:775","journal-title":"J Am Coll Cardiol"},{"key":"4157_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00392-011-0393-1","volume":"101","author":"Zeymer","year":"2012","unstructured":"Zeymer U, Arntz HR, Mark B et al (2012) Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol 101:305\u2013312","journal-title":"Clin Res Cardiol"},{"key":"4157_CR11","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/eurheartj\/ehr360","volume":"32","author":"D\u00f6rler","year":"2011","unstructured":"D\u00f6rler J, Edlinger M, Alber HF et al (2011) Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Eur Heart J 32:2954\u20132961","journal-title":"Eur Heart J"},{"key":"4157_CR12","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1093\/eurheartj\/ehr202","volume":"32","author":"Koul","year":"2011","unstructured":"Koul S, Smith JG, Scherst\u00e9n F et al (2011) Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 32:2989\u20132997","journal-title":"Eur Heart J"},{"key":"4157_CR13","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/CIRCULATIONAHA.107.749531","volume":"118","author":"Vlaar","year":"2008","unstructured":"Vlaar PJ, Svilaas T, Damman K et al (2008) Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review. Circulation 118:1828\u20131836","journal-title":"Circulation"},{"key":"4157_CR14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/11599830-000000000-00000","volume":"51","author":"Husted","year":"2012","unstructured":"Husted SE, Storey RF, Bliden K et al (2012) Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studies. Clin Pharmacokinet 51:397\u2013409","journal-title":"Clin Pharmacokinet"},{"key":"4157_CR15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehp159","volume":"30","author":"Michelson","year":"2009","unstructured":"Michelson AD, Frelinger AL III, Braunwald E et al (2009) Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. Eur Heart J 30:1753\u20131763","journal-title":"Eur Heart J"},{"key":"4157_CR16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/eurheartj\/ehu214","volume":"35","author":"Zeymer","year":"2014","unstructured":"Zeymer U, Mochmann HC, Mark B et al (2014) More rapid platelet inhibition with prehospital administration of 60\u00a0mg prasugrel compared to 600\u00a0mg clopidogrel in patients with STEMI and primary PCI. The double-blind, randomized ETAMI trial. Eur Heart J 35(Suppl 1):546","journal-title":"Eur Heart J"},{"key":"4157_CR17","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.amjcard.2013.07.010","volume":"112","author":"Beigel","year":"2013","unstructured":"Beigel R, Fefer P, Rosenberg N et al (2013) Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction. Am J Cardiol 112:1551\u20131556","journal-title":"Am J Cardiol"},{"key":"4157_CR18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ahj.2012.12.015","volume":"165","author":"Montalescot","year":"2013","unstructured":"Montalescot G, Lassen JF, Hamm CW et al (2013) Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study. Am Heart J 165:515\u2013522","journal-title":"Am Heart J"},{"key":"4157_CR19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","volume":"371","author":"Montalescot","year":"2014","unstructured":"Montalescot G, Hof AW van \u201at, Lapostolle F et al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 371:1016\u20131027","journal-title":"N Engl J Med"},{"key":"4157_CR20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2013.01.024","volume":"61","author":"Parodi","year":"2013","unstructured":"Parodi G, Valenti R, Bellandi B et al (2013) Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. J Am Coll Cardiol 61:1601\u20131606","journal-title":"J Am Coll Cardiol"},{"key":"4157_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCINTERVENTIONS.113.001118","volume":"7","author":"Alexopoulos","year":"2014","unstructured":"Alexopoulos D, Makris G, Xanthopoulou I et al (2014) Onset of antiplatelet action with high (100\u00a0mg) versus standard (60\u00a0mg) loading dose of prasugrel in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: pharmacodynamic study. Circ Cardiovasc Interv 7:233\u2013239","journal-title":"Circ Cardiovasc Interv"},{"key":"4157_CR22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jacc.2013.05.021","volume":"62","author":"Alexopoulos","year":"2013","unstructured":"Alexopoulos D, Gkizas V, Patsilinakos S et al (2013) Double versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI. J Am Coll Cardiol 62:940\u2013941","journal-title":"J Am Coll Cardiol"},{"key":"4157_CR23","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/j.ijcard.2013.06.078","volume":"168","author":"Fournier","year":"2013","unstructured":"Fournier N, Toesca R, Bessereau J et al (2013) Ticagrelor or prasugrel for pre-hospital protocols in STEMI? Int J Cardiol 168:4566\u20134567","journal-title":"Int J Cardiol"},{"key":"4157_CR24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1172\/JCI119307","volume":"99","author":"Coller","year":"1997","unstructured":"Coller BS (1997) Platelet GP IIb\/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 99:1467\u20131471","journal-title":"J Clin Invest"},{"key":"4157_CR25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(06)68148-8","volume":"367","author":"Keeley","year":"2006","unstructured":"Keeley EC, Boura JA, Grines CL (2006) Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 367:579\u2013588","journal-title":"Lancet"},{"key":"4157_CR26","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.jacc.2009.11.091","volume":"55","author":"Berg","year":"2010","unstructured":"Berg JM ten, Hof AW van \u201at, Dill T et al (2010) Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. J Am Coll Cardiol 55:2446\u20132455","journal-title":"J Am Coll Cardiol"},{"key":"4157_CR27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/ccd.23165","volume":"79","author":"Hermanides","year":"2012","unstructured":"Hermanides RS, Werkum JW van, Ottervanger JP et al (2012) The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI. Catheter Cardiovasc Interv 79:956\u2013964","journal-title":"Catheter Cardiovasc Interv"},{"key":"4157_CR28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ahj.2010.08.039","volume":"160","author":"Heestermans","year":"2010","unstructured":"Heestermans T, Hof AW van \u201at, Berg JM ten et al (2010) The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy. Am Heart J 160:1079\u20131084","journal-title":"Am Heart J"},{"key":"4157_CR29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcin.2012.01.006","volume":"5","author":"Valgimigli","year":"2012","unstructured":"Valgimigli M, Tebaldi M, Campo G et al (2012) Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. JACC Cardiovasc Interv 5:268\u2013277","journal-title":"JACC Cardiovasc Interv"},{"key":"4157_CR30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1055\/s-0031-1299012","volume":"137","author":"Bauer","year":"2012","unstructured":"Bauer T, Zahn R (2012) Modern treatment in acute coronary syndrome. Dtsch Med Wochenschr 137:722\u2013725","journal-title":"Dtsch Med Wochenschr"},{"key":"4157_CR31","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999\u20133054","journal-title":"Eur Heart J"},{"key":"4157_CR32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","volume":"369","author":"Montalescot","year":"2013","unstructured":"Montalescot G, Bolognese L, Dudek D et al (2013) Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 369:999\u20131010","journal-title":"N Engl J Med"},{"key":"4157_CR33","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","volume":"367","author":"Roe","year":"2012","unstructured":"Roe MT, Armstrong PW, Fox KA et al (2012) Prasugrel versus clopidogrel for acute coronary syndromes. N Engl J Med 367:1297\u20131309","journal-title":"N Engl J Med"},{"key":"4157_CR34","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH et al; TRITON-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"4157_CR35","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehu160","volume":"35","author":"Lindholm","year":"2014","unstructured":"Lindholm D, Varenhorst C, Cannon CP et al (2014) Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J 35:2083\u20132093","journal-title":"Eur Heart J"},{"key":"4157_CR36","doi-asserted-by":"crossref","unstructured":"Held C, Asenblad N, Bassand JP et al (2011) Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 57\u2013:672\u2013684","DOI":"10.1016\/j.jacc.2010.10.029"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-014-4157-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-014-4157-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T04:54:17Z","timestamp":1565931257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-014-4157-3"}},"subtitle":["Pr\u00e4hospitale Phase: nichts, ASS oder...?"],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1007\/s00059-014-4157-3","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]}}}